Skip to main content
logo
Appili Therapeutics Inc. (TSX:APLI)
Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
Aug 10, 2026, 9:08 AM EST

Appili Therapeutics Balance Sheet

Millions CAD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
0.041.230.092.476.66
Cash & Short-Term Investments
0.041.230.092.476.66
Cash Growth
-96.74%1199.83%-96.17%-63.00%-58.67%
Accounts Receivable
1.791.661.160.120.47
Other Receivables
0.010.010.020.30.92
Total Trade Receivables
1.81.671.170.421.39
Other Current Assets
0.120.110.190.230.18
Total Current Assets
1.963.011.463.128.24
Net Property, Plant & Equipment
0.010.020.030.010.04
Total Assets
1.973.031.493.138.28

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
6.34.114.182.826.46
Current Portion of Long-Term Debt
12.2611.567.310.110.1
Unearned Revenue
----0.12
Other Current Liabilities
0.060.030.050.04-
Total Current Liabilities
18.6315.6911.542.986.67
Long-Term Debt
0.670.740.887.554.88
Total Long-Term Liabilities
0.670.740.887.554.88
Total Liabilities
19.316.4312.4210.5311.55

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Shareholders' Equity
-17.33-13.4-10.92-7.4-3.27
Total Liabilities & Equity
1.973.031.493.138.28

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
12.9412.298.187.674.98
Net Cash (Debt)
-12.9-11.07-8.09-5.21.69
Net Cash Growth
-----88.83%
Net Cash Per Share
-0.10-0.09-0.07-0.050.03